Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil

Medicine & Life Sciences

• Brazil 56%
• Direct-To-Consumer Screening and Testing 53%
• Delivery of Health Care 38%
• Genetic Heterogeneity 36%
• Neonatal Screening 36%
• Genetic Testing 32%
• Informed Consent 30%
• Genetic Variation 30%
• Inborn Genetic Diseases 28%
• Genome 21%
• Education 19%
• Costs and Cost Analysis 19%
• Mutation 17%
• Growth 15%
• Genes 12%
• Therapeutics 5%

Social Sciences

• Health care patients 100%
• Health care professionals 68%
• Brazil 46%
• genetic diagnosis 13%
• Genetic information 11%
• ethical implications 10%
• Regulatory framework 9%
• informed consent 9%
• Clinical Practice 8%
• economy 5%
• interpretation 5%
• costs 5%
• lack 4%
• education 2%